Clinical Trials in Denver

Showing 7781-7800 of 18,161 trials

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

NCT05268666

The purpose of this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of JBI-802 in patients with Advanced Solid Tumors.The efficacy of the RP2D will be evaluated in phase 2 in patients with solid tumors of neuroendocrine differentiation.

Locally Advanced Solid TumorMetastatic Solid Tumor

Jubilant Therapeutics Inc.126 participantsStarted Apr 2022

Denver, Colorado, United States • Cincinnati, Ohio, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

NCT00004860

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of fluorouracil-uracil and leucovorin in treating elderly patients who have metastatic colorectal cancer.

Colorectal Cancer

Eastern Cooperative Oncology GroupStarted Oct 2000

Scottsdale, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +48 more locations

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Find Trials by Condition in Denver

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

A New Securement Method for External Tunneled Central Venous Access Devices (CVAD)

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Ventral Hernia Study Using OviTex Reinforced Bioscaffold

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143

Evaluation of FDY-5301 in Major Trauma Patients in ICU